Trials / Conditions / Embryonal Childhood Rhabdomyosarcoma

Embryonal Childhood Rhabdomyosarcoma

8 registered clinical trials studyying Embryonal Childhood Rhabdomyosarcoma.

Status	Trial	Sponsor	Phase
Completed	Retrospective Study in FFPE Samples From Younger Patients With Rhabdomyosarcoma NCT06040229	Shandong First Medical University	—
Completed	Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma NCT01609803	Children's Oncology Group	—
Completed	Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma NCT01626170	Children's Oncology Group	—
Completed	Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma NCT01496573	Children's Oncology Group	—
Completed	Ixabepilone in Treating Young Patients With Refractory Solid Tumors NCT00331643	National Cancer Institute (NCI)	Phase 2
Completed	Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Ne NCT00075582	Children's Oncology Group	Phase 3
Completed	Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma NCT00003958	Children's Oncology Group	Phase 3
Completed	Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma NCT00025363	National Cancer Institute (NCI)	Phase 2